Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis
NCT ID: NCT03006783
Last Updated: 2016-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2016-03-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Imagery analysis
* Questionnaires
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cross-face nerve graft treated
People treated by a solitary cross-face nerve graft or in combination with another procedure.
Cross-face nerve graft
connecting the healthy facial nerve to the affected facial nerve
Hypoglossal-facial treated
People treated with a solitary hypoglossal-facial anastomosis.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cross-face nerve graft
connecting the healthy facial nerve to the affected facial nerve
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Center Groningen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tijn van Veen
M.M. van Veen, BSc
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TvanVeen
Identifier Type: -
Identifier Source: org_study_id